Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-16 17:51 |
FORM 6-K-Second Quarter 2024 Financial Results and Business Highlights
|
English | 36.8 KB | ||
| 2024-08-09 01:42 |
FORM 6-K -e results of the Annual General Meeting of Shareholders of the Compan…
|
English | 123.0 KB | ||
| 2024-08-09 01:42 |
FORM 6-K -e results of the Annual General Meeting of Shareholders of the Compan…
|
English | 36.9 KB | ||
| 2024-08-06 02:07 |
Mr. Lior Fhima, who serves as the Company’s Chief Financial Officer, notified t…
|
English | 123.3 KB | ||
| 2024-08-06 02:07 |
Mr. Lior Fhima, who serves as the Company’s Chief Financial Officer, notified t…
|
English | 36.7 KB | ||
| 2024-07-31 15:09 |
PROSPECTUS - up to an aggregate of11,661,364 American Depositary Shares represe…
|
English | 280.4 KB | ||
| 2024-07-31 15:09 |
PROSPECTUS - up to an aggregate of11,661,364 American Depositary Shares represe…
|
English | 35.9 KB | ||
| 2024-07-25 16:45 |
Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
|
English | 168.3 KB | ||
| 2024-07-25 16:45 |
Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
|
English | 36.7 KB | ||
| 2024-07-23 02:10 |
FORM F-1-ADS resale by the selling shareholders
|
English | 1.4 MB | ||
| 2024-07-23 02:10 |
FORM F-1-ADS resale by the selling shareholders
|
English | 35.8 KB | ||
| 2024-07-21 00:24 |
Corporate Presentation July 2024
|
English | 26.9 MB | ||
| 2024-07-21 00:24 |
Corporate Presentation July 2024
|
English | 36.6 KB | ||
| 2024-07-16 01:33 |
FORM D-Notice of Exempt Offering of Securities
|
English | 158.3 KB | ||
| 2024-07-16 01:33 |
FORM D-Notice of Exempt Offering of Securities
|
English | 36.6 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
